泌尿系肿瘤幸存者当前吸烟、戒烟尝试与戒烟咨询模式:全国代表性横断面分析
基于美国全国健康访谈调查(2014-2018)的横断面分析,比较吸烟相关泌尿系肿瘤(肾癌或膀胱癌)与前列腺癌幸存者的当前吸烟率、戒烟尝试及戒烟咨询接受情况。吸烟相关泌尿系肿瘤幸存者当前吸烟率更高(14.8% vs 8.6%,p<0.001),接受戒烟咨询更频繁(79.8% vs 66.2%,p=0.02),但戒烟尝试率无差异(52.4% vs 47.2%,p=0.44);校正社会人口学混杂后肿瘤类型与当前吸烟无关联(OR 1.23,95%CI 0.86-1.77)。
要点
- 吸烟相关泌尿系肿瘤幸存者当前吸烟率高于前列腺癌幸存者(14.8% vs 8.6%)。
- 前者接受戒烟咨询更频繁,但戒烟尝试率与前列腺癌幸存者无差异。
- 所有泌尿系肿瘤幸存者的吸烟率随时间趋势保持稳定且持续。
核心结论
- 吸烟相关泌尿系肿瘤幸存者当前吸烟率高于前列腺癌幸存者,但戒烟尝试率无差异。
- 校正社会人口学混杂因素后,肿瘤类型与当前吸烟无显著关联(OR 1.23,95%CI 0.86-1.77)。
- 年龄较大和教育程度较高与当前吸烟几率降低相关,单身婚姻状态与吸烟几率升高相关。
研究设计与样本
- 基于美国全国健康访谈调查(2014-2018)的横断面分析。
- 共2,664名受访者报告泌尿系肿瘤病史,加权估计吸烟相关泌尿系肿瘤990,820名成人、前列腺癌2,616,596名成人。
- 采用回归分析评估吸烟相关泌尿系肿瘤病史与诊断后继续吸烟的关联。
主要发现
- 吸烟相关泌尿系肿瘤幸存者当前吸烟率为14.8%,前列腺癌幸存者为8.6%(p<0.001)。
- 吸烟相关泌尿系肿瘤幸存者接受戒烟咨询比例为79.8%,前列腺癌幸存者为66.2%(p=0.02)。
- 两组戒烟尝试率分别为52.4%和47.2%(p=0.44)。
- 时间趋势显示所有泌尿系肿瘤幸存者的吸烟使用保持稳定且持续。
关键数值与推荐
- 当前吸烟率:吸烟相关泌尿系肿瘤14.8% vs 前列腺癌8.6%,p<0.001。
- 戒烟咨询接受率:79.8% vs 66.2%,p=0.02。
- 戒烟尝试率:52.4% vs 47.2%,p=0.44。
- 校正后肿瘤类型与当前吸烟:OR 1.23,95%CI 0.86-1.77。
临床怎么用
- 对吸烟相关泌尿系肿瘤幸存者应强化戒烟干预,尤其关注单身、年轻及教育程度较低者。
- 戒烟咨询接受率虽较高,但戒烟尝试率未相应提高,提示咨询质量或干预强度需加强。
- 将戒烟支持纳入泌尿系肿瘤 survivorship 常规管理。
局限性
- 横断面设计无法确定因果方向。
- 吸烟与戒烟行为依赖自我报告,可能存在回忆偏倚。
- 数据来自2014-2018年,可能不完全反映当前模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cigarette smoking is the leading modifiable risk factor for several genitourinary malignancies. Although smoking cessation after genitourinary cancer diagnosis is a critical component of survivorship, factors related to continued smoking are under studied. MATERIALS AND METHODS: A cross-sectional analysis was conducted using data from the National Health Interview Survey (2014-2018). Our primary study outcome was the prevalence and correlates of cigarette smoking among adults with a history of smoking-related (kidney or bladder) urological cancer compared to a nonsmoking-related control (prostate cancer). We used regression analyses to assess the association of having a smoking-related genitourinary cancer history with continued cigarette smoking after diagnosis. Secondary outcomes were yearly smoking trends, quit attempts and reported receipt of smoking cessation counseling. RESULTS: A total of 2,664 respondents reported a history of genitourinary cancer, representing weighted estimates of 990,820 (smoking-related genitourinary cancer) and 2,616,596 (prostate cancer) adults. Survivors of smoking-related genitourinary cancers had a significantly higher overall prevalence of current cigarette use (14.8% vs 8.6%, p <0.001) and also reported more frequent receipt of counseling (79.8% vs 66.2%, p=0.02) but did not attempt to quit any more often than those with prostate cancer (52.4% vs 47.2%, p=0.44). Time trends demonstrated stable and persistent cigarette use among survivors of all genitourinary cancers. After adjustment for sociodemographic confounders, cancer type was not associated with current cigarette smoking (OR 1.23, 95% CI 0.86-1.77). However, older age and more advanced educational attainment were associated with lower odds of current cigarette smoking, while single marital status was associated with higher odds. CONCLUSIONS: In this population-based cross-sectional study of survivors of genitourinary cancers, those with a reported smoking-related genitourinary cancer had a higher prevalence of current cigarette smoking compared to those with prostate cancer, our nonsmoking-related control. Those with smoking-related genitourinary cancers reported more frequent receipt of smoking cessation counseling.
引用
- Matulewicz RS, Basak R, Zambrano I, et al. Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis. J Urol. 2020. PMID: 33347778. doi:10.1097/JU.0000000000001483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。